William Chester Patt | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where William Chester Patt is active.

Explore More

Publication

Featured researches published by William Chester Patt.

Journal of Medicinal Chemistry | 1992

Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors

William Chester Patt; Harriet W. Hamilton; Michael Douglas Taylor; Michael J. Ryan; David G. Taylor; Cleo Connolly; Annette M. Doherty; Sylvester R. Klutchko; Ila Sircar

Archive | 2002

Quinazolines as mmp-13 inhibitors

Charles Andrianjara; Nicole Chantel Barvian; Bernard Gaudilliere; Henri Jacobelli; Daniel F. Ortwine; William Chester Patt; Ly Pham; Catherine Rose Kostlan; Michael William Wilson

Journal of Medicinal Chemistry | 1989

N6-Bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor

Bharat Trivedi; Alexander James Bridges; William Chester Patt; S. R. Priebe; Robert F. Bruns

Archive | 2002

Pyridine matrix metalloproteinase inhibitors

Nicole Chantel Barvian; David T. Connor; Patrick Michael O'brien; Daniel F. Ortwine; William Chester Patt; Kevon Ray Ann Arbor Laboratories Shuler; Michael William Wilson

Archive | 2002

Pyrimidine matrix metalloproteinase inhibitors

Nicole Chantel Barvian; William Chester Patt

Bioorganic & Medicinal Chemistry Letters | 2010

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.

Mark E. Schnute; Patrick Michael O'brien; Joe Nahra; Mark Morris; W. Howard Roark; Cathleen E. Hanau; Peter G. Ruminski; Jeffrey A. Scholten; Theresa R. Fletcher; Bruce C. Hamper; Jeffery N. Carroll; William Chester Patt; Huey Shieh; Brandon Collins; Alexander Pavlovsky; Katherine E. Palmquist; Karl W. Aston; Jeffrey Hitchcock; Michael D. Rogers; Joseph J. Mcdonald; Adam R. Johnson; Grace E. Munie; Arthur J. Wittwer; Chiu-Fai Man; Steven L. Settle; Olga V. Nemirovskiy; Lillian E. Vickery; Arun Agawal; Richard D. Dyer; Teresa Sunyer

Archive | 2002

Isophthalic acid derivatives as matrix metalloproteinase inhibitors

Nicole Chantel Barvian; David T. Connor; Richard D. Dyer; Adam R. Johnson; William Chester Patt

Journal of Medicinal Chemistry | 1986

Ribose-modified adenosine analogues as adenosine receptor agonists

Michael D. Taylor; Walter H. Moos; Harriet W. Hamilton; Deedee S. Szotek; William Chester Patt; Edward W. Badger; James A. Bristol; Robert F. Bruns; Thomas G. Heffner; Thomas E. Mertz

Archive | 2003

Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k

Nicole Chantel Barvian; Christine Nylund Kolz; Kimberly Suzanne Para; William Chester Patt; Melean Visnick

Journal of Medicinal Chemistry | 1992

Perfluorocarbon-based antidiabetic agents.

Kenneth L. Kees; Ted M. Smith; Michael L. McCaleb; Dorothy H. Prozialeck; Robert Scott Cheeseman; Thomas E. Christos; William Chester Patt; Kurt E. Steiner

Explore More